534 related articles for article (PubMed ID: 18347094)
21. Reprogramming of human somatic cells to pluripotency with defined factors.
Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
[TBL] [Abstract][Full Text] [Related]
22. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.
Fong H; Hohenstein KA; Donovan PJ
Stem Cells; 2008 Aug; 26(8):1931-8. PubMed ID: 18388306
[TBL] [Abstract][Full Text] [Related]
23. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation.
Gu P; LeMenuet D; Chung AC; Mancini M; Wheeler DA; Cooney AJ
Mol Cell Biol; 2005 Oct; 25(19):8507-19. PubMed ID: 16166633
[TBL] [Abstract][Full Text] [Related]
24. The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture.
Perrett RM; Turnpenny L; Eckert JJ; O'Shea M; Sonne SB; Cameron IT; Wilson DI; Rajpert-De Meyts E; Hanley NA
Biol Reprod; 2008 May; 78(5):852-8. PubMed ID: 18199879
[TBL] [Abstract][Full Text] [Related]
25. OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells.
Navarro P; Festuccia N; Colby D; Gagliardi A; Mullin NP; Zhang W; Karwacki-Neisius V; Osorno R; Kelly D; Robertson M; Chambers I
EMBO J; 2012 Dec; 31(24):4547-62. PubMed ID: 23178592
[TBL] [Abstract][Full Text] [Related]
26. A competitive protein interaction network buffers Oct4-mediated differentiation to promote pluripotency in embryonic stem cells.
Muñoz Descalzo S; Rué P; Faunes F; Hayward P; Jakt LM; Balayo T; Garcia-Ojalvo J; Martinez Arias A
Mol Syst Biol; 2013 Oct; 9():694. PubMed ID: 24104477
[TBL] [Abstract][Full Text] [Related]
27. Ethanol alters the balance of Sox2, Oct4, and Nanog expression in distinct subpopulations during differentiation of embryonic stem cells.
Ogony JW; Malahias E; Vadigepalli R; Anni H
Stem Cells Dev; 2013 Aug; 22(15):2196-210. PubMed ID: 23470161
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.
Yang J; Chai L; Fowles TC; Alipio Z; Xu D; Fink LM; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19756-61. PubMed ID: 19060217
[TBL] [Abstract][Full Text] [Related]
30. Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells.
Levasseur DN; Wang J; Dorschner MO; Stamatoyannopoulos JA; Orkin SH
Genes Dev; 2008 Mar; 22(5):575-80. PubMed ID: 18283123
[TBL] [Abstract][Full Text] [Related]
31. Generation and characterization of a novel mouse embryonic stem cell line with a dynamic reporter of Nanog expression.
Abranches E; Bekman E; Henrique D
PLoS One; 2013; 8(3):e59928. PubMed ID: 23527287
[TBL] [Abstract][Full Text] [Related]
32. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
33. Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors.
Liao J; Wu Z; Wang Y; Cheng L; Cui C; Gao Y; Chen T; Rao L; Chen S; Jia N; Dai H; Xin S; Kang J; Pei G; Xiao L
Cell Res; 2008 May; 18(5):600-3. PubMed ID: 18414447
[No Abstract] [Full Text] [Related]
34. Fibroblast growth factor receptor 2 homodimerization rapidly reduces transcription of the pluripotency gene Nanog without dissociation of activating transcription factors.
Santostefano KE; Hamazaki T; Pardo CE; Kladde MP; Terada N
J Biol Chem; 2012 Aug; 287(36):30507-17. PubMed ID: 22787153
[TBL] [Abstract][Full Text] [Related]
35. Partial inhibition of differentiation associated with elevated protein levels of pluripotency factors in mouse embryonic stem cells expressing exogenous EGAM1N homeoprotein.
Sato S; Nakazawa M; Kihara Y; Kubo Y; Sato Y; Kikuchi T; Nonaka A; Sasaki A; Iwashita J; Murata J; Hosaka M; Kobayashi M
J Biosci Bioeng; 2015 Nov; 120(5):562-9. PubMed ID: 25817697
[TBL] [Abstract][Full Text] [Related]
36. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
37. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells.
Liang J; Wan M; Zhang Y; Gu P; Xin H; Jung SY; Qin J; Wong J; Cooney AJ; Liu D; Songyang Z
Nat Cell Biol; 2008 Jun; 10(6):731-9. PubMed ID: 18454139
[TBL] [Abstract][Full Text] [Related]
38. Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination.
Johansson H; Simonsson S
Aging (Albany NY); 2010 Nov; 2(11):815-22. PubMed ID: 21076177
[TBL] [Abstract][Full Text] [Related]
39. Role for Med12 in regulation of Nanog and Nanog target genes.
Tutter AV; Kowalski MP; Baltus GA; Iourgenko V; Labow M; Li E; Kadam S
J Biol Chem; 2009 Feb; 284(6):3709-18. PubMed ID: 19036726
[TBL] [Abstract][Full Text] [Related]
40. Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.
Kalmar T; Lim C; Hayward P; Muñoz-Descalzo S; Nichols J; Garcia-Ojalvo J; Martinez Arias A
PLoS Biol; 2009 Jul; 7(7):e1000149. PubMed ID: 19582141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
